학술논문
Synthesis, α‐glucosidase Inhibition, in silico Pharmacokinetic, and Docking Studies Of Thieno[2,3‐b]Quinoline‐Acetamide Derivatives as New Anti‐Diabetic Agents.
Document Type
Article
Author
Source
Subject
*MOLECULAR docking
*BINDING sites
*PHARMACOKINETICS
*CHEMICAL synthesis
*ACETAMIDE derivatives
*ACARBOSE
*
*
*
*
*
Language
ISSN
2365-6549
Abstract
In this work, novel anti‐α‐glucosidase agents, thieno[2,3‐b]quinoline‐acetamide derivatives 5 a–m have been designed and synthesized. These compounds were evaluated in vitro against yeast α‐glucosidase. Most of the title new compounds exhibited a significant α‐glucosidase inhibitory activity in comparison to positive control, acarbose. In this regards, the most potent compound amongst the tested compounds, compound 5 k, with IC50=48.66±0.02 μM was 15.6‐fold more potent than acarbose. Compound 5 k was a competitive inhibitor into α‐glucosidase and interacted with important residues of the active site of this enzyme. Three most potent compounds among the newly synthesized compounds 5 j–k and 5 m were evaluated in silico in term of the oral druglikeness and pharmacokinetic properties. The obtained results predicted that these compounds had satisfactory oral druglikeness and pharmacokinetic properties. [ABSTRACT FROM AUTHOR]